Literature DB >> 25009274

Presynaptic inhibition by α2 receptor/adenylate cyclase/PDE4 complex at retinal rod bipolar synapse.

Cun-Jian Dong1, Yuanxing Guo2, Yilin Ye2, William A Hare2.   

Abstract

G-protein-coupled receptor (GPCR)-mediated presynaptic inhibition is a fundamental mechanism regulating synaptic transmission in the CNS. The classical GPCR-mediated presynaptic inhibition in the CNS is produced by direct interactions between the G(βγ) subunits of the G-protein and presynaptic Ca(2+) channels, K(+) channels, or synaptic proteins that affect transmitter release. This mode of action is shared by well known GPCRs such as the α2, GABA(B), and CB1 receptors. We report that the α2 receptor-mediated inhibition of presynaptic Ca(2+) channel and transmitter release in rat retinal rod bipolar cells depends on the G(α) subunit via a G(α)-adenylate cyclase-cAMP cascade and requires participation of the type 4 phosphodiesterase (PDE4), a new role for phosphodiesterase in neural signaling. By using the G(α) instead of the G(βγ) subunits, this mechanism is able to use a cyclase/PDE enzyme pair to dynamically control a cyclic nucleotide second messenger (i.e., cAMP) for the regulation of synaptic transmission, an operating strategy that shows remarkable similarity to that of dynamic control of cGMP and transmitter release from photoreceptors by the guanylate cyclase/PDE6 pair in phototransduction. Our results demonstrate a new paradigm of GPCR-mediated presynaptic inhibition in the CNS and add a new regulatory mechanism at a critical presynaptic site in the visual pathway that controls the transmission of scotopic information. They also provide a presynaptic mechanism that could contribute to neuroprotection of retinal ganglion cells by α2 agonists, such as brimonidine, in animal models of glaucoma and retinal ischemia and in glaucoma patients.
Copyright © 2014 the authors 0270-6474/14/349432-09$15.00/0.

Entities:  

Keywords:  Ca2+ channel; GPCR; PDE4; presynaptic inhibition; α2 receptor

Mesh:

Substances:

Year:  2014        PMID: 25009274      PMCID: PMC6608359          DOI: 10.1523/JNEUROSCI.0766-14.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  4 in total

1.  Circular RNAs in human and vertebrate neural retinas.

Authors:  Lan-Fang Sun; Bing Zhang; Xue-Jiao Chen; Xiao-Yun Wang; Bo-Wen Zhang; Yang-Yang Ji; Kun-Chao Wu; Jinyu Wu; Zi-Bing Jin
Journal:  RNA Biol       Date:  2019-04-02       Impact factor: 4.652

2.  NeuroRDF: semantic integration of highly curated data to prioritize biomarker candidates in Alzheimer's disease.

Authors:  Anandhi Iyappan; Shweta Bagewadi Kawalia; Tamara Raschka; Martin Hofmann-Apitius; Philipp Senger
Journal:  J Biomed Semantics       Date:  2016-07-08

3.  Novel Anti-Inflammatory Effects of Brimonidine on Propionibacterium acnes-Induced Inflammatory Reaction.

Authors:  So-Ra Choi; Jin Gwi Yoo; Soo Jung Kim; Chong Won Choi; Young Lee; ChangDeok Kim; Young-Joon Seo; Jeung-Hoon Lee; Myung Im; Kyung Duck Park
Journal:  Ann Dermatol       Date:  2020-06-30       Impact factor: 1.444

4.  Comparisons of α2-Adrenergic Agents, Medetomidine and Xylazine, with Pentobarbital for Anesthesia: Important Pitfalls in Diabetic and Nondiabetic Rats.

Authors:  Anna R Connell; Michelle B Hookham; Dongxu Fu; Derek P Brazil; Timothy J Lyons; Jeremy Y Yu
Journal:  J Ocul Pharmacol Ther       Date:  2021-12-29       Impact factor: 2.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.